Recessive mutations in several genes, including the ATPase type 13A2 gene (ATP13A2/PARK9), can cause neurodegeneration with a very young (juvenile) onset, usually presenting with other clinical signs in addition to parkinsonism (such as dystonia, oculomotor disturbances, pyramidal signs, and dementia). This evidence concerns the gene ATP13A2 and Parkinson disease.